The global demerol meperidine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the growth of the market during the forecast period include the growth in the incidence of infectious diseases & chronic pain and a rise in disposable income and a surge in the geriatric population. However, the emergence and legalization of alternative treatments of opioids such as cannabis impede the growth of the market. Moreover, the growing demand for meperidine associated with its higher usage as an anaesthetic in different surgical procedures is expected to drive the global meperidine (demerol) market growth. For instance, according to the World Health Organization (WHO) 2021, it is estimated that 143 million surgical procedures are required across the world each year to save lives and prevent disability. This, in turn, is driving the demand for demerol meperidine as it used before and during surgery with other kinds of pain medication. 

Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. Meperidine is used to treat moderate-to-severe pain. In addition, the increasing incidence of cancer across the globe is expected to drive the global Meperidine (Demerol) market. For instance, according to National Cancer Institute, it was estimated that 1,806,590 new cases of cancer would be diagnosed in the US and 606,520 people would die from the disease in 2020. This results in increasing demand for demerol (meperidine) for cancer patients as it is used for the treatment of moderate to severe pain. However, there are several concerns about adverse reactions, drug interactions, and normeperidine neurotoxicity which hamper the market growth

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Product Type 

o By Application 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Boehringer Ingelheim GmbH, Pfizer Inc., and Sanofi S.A., among others. 

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Demerol Meperidine Market Report by Segment

By Product Type

• Powder
• Liquid

By Application

• Anaesthesia
• Cough Treatment
• Diarrhoea Treatment

Global Demerol Meperidine Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa